Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2010 2
2011 2
2012 7
2013 1
2014 1
2015 2
2016 1
2017 5
2018 4
2019 4
2020 7
2021 10
2022 9
2023 9
2024 1
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Results by year

Filters applied: . Clear all
Page 1
Large language models-enabled digital twins for precision medicine in rare gynecological tumors.
Lammert J, Pfarr N, Kuligin L, Mathes S, Dreyer T, Modersohn L, Metzger P, Ferber D, Kather JN, Truhn D, Adams LC, Bressem KK, Lange S, Schwamborn K, Boeker M, Kiechle M, Schatz UA, Bronger H, Tschochohei M. Lammert J, et al. Among authors: bronger h, dreyer t. NPJ Digit Med. 2025 Jul 9;8(1):420. doi: 10.1038/s41746-025-01810-z. NPJ Digit Med. 2025. PMID: 40634659 Free PMC article.
Two-dimensional analysis of plasma-derived extracellular vesicles to determine the HER2 status in breast cancer patients.
Wilhelm A, Flynn C, Hammer E, Roessler J, Haller B, Napieralski R, Leuthner M, Tosheska S, Knoops K, Mathew A, Ciarimboli G, Kranich J, Flaskamp L, King S, Gevensleben H, Emslander Q, Pastucha A, Reisbeck M, Rief L, Bronger H, Dreyer T, Bausch AR, Pichlmair A, Brocker T, Zeidler R, Hammerschmidt W, Piedavent-Salomom M, López-Iglesias C, Schricker G, Haydn O, Kiechle M, Grill S, Heeren R, Knolle PA, Wilhelm O, Höchst B. Wilhelm A, et al. Among authors: bronger h, dreyer t. Breast Cancer Res. 2025 Jun 16;27(1):107. doi: 10.1186/s13058-025-02056-z. Breast Cancer Res. 2025. PMID: 40524202 Free PMC article.
Evaluation of Baseline Characteristics and Therapeutic Management Strategies in Metastatic Cervical Cancer in Germany: A Multicentric Retrospective Longitudinal Observational Study: A Quality Assurance Initiative of the AGO-Study Group and AGO-OK Uterus.
Denschlag D, Czogalla B, Heitz F, Kerkmann M, Fangmann LC, Klecker PH, Stuebs FA, Wölber L, Radosa J, Lodde PC, Seitz S, George C, Mach P, Fink A, Bokhua D, deGregorio N, Lampe B, Hemptenmacher F, Friebe V, Fleisch M, Wimberger P, Jaeger A, Schnelzer A, Mittelstadt S, Ratiu D, Eichbaum M, Haus A, Kalder M, Ataseven B, Schröder W, Bronger H, Kosse J, Ulrich UA, Elser G, Harter P. Denschlag D, et al. Among authors: bronger h. Geburtshilfe Frauenheilkd. 2025 May 15;85(5):520-532. doi: 10.1055/a-2520-5736. eCollection 2025 May. Geburtshilfe Frauenheilkd. 2025. PMID: 40386500 Free PMC article.
The chemokine CX3CL1 promotes intraperitoneal tumour growth despite enhanced T-cell recruitment in ovarian cancer.
Seitz S, Dreyer TF, Stange C, Steiger K, Wohlleber D, Anton M, Pham TA, Sauter-Peschke D, Reuning U, Multhoff G, Weichert W, Kiechle M, Magdolen V, Bronger H. Seitz S, et al. Among authors: bronger h, reuning u, dreyer tf, magdolen v. Neoplasia. 2025 Feb;60:101130. doi: 10.1016/j.neo.2025.101130. Epub 2025 Jan 24. Neoplasia. 2025. PMID: 39862711 Free PMC article.
Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial.
Harter P, Marth C, Mouret-Reynier MA, Cropet C, Lorusso D, Guerra-Alía EM, Matsumoto T, Vergote I, Colombo N, Mäenpää J, Lebreton C, de Gregorio N, Mosconi AM, Rubio-Pérez MJ, Bourgeois H, Fasching PA, Cecere SC, Hardy-Bessard AC, Denschlag D, de Percin S, Hanker L, Favier L, Bauerschlag D, Desauw C, Hillemanns P, Largillier R, Sehouli J, Grenier J, Pujade-Lauraine E, Ray-Coquard I; PAOLA-1/ENGOT-ov25 investigators. Harter P, et al. Ann Oncol. 2025 Feb;36(2):185-196. doi: 10.1016/j.annonc.2024.10.828. Epub 2024 Nov 9. Ann Oncol. 2025. PMID: 39528049 Free article. Clinical Trial.
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.
Moore KN, Angelergues A, Konecny GE, García Y, Banerjee S, Lorusso D, Lee JY, Moroney JW, Colombo N, Roszak A, Tromp J, Myers T, Lee JW, Beiner M, Cosgrove CM, Cibula D, Martin LP, Sabatier R, Buscema J, Estévez-García P, Coffman L, Nicum S, Duska LR, Pignata S, Gálvez F, Wang Y, Method M, Berkenblit A, Bello Roufai D, Van Gorp T; Gynecologic Oncology Group Partners and the European Network of Gynaecological Oncological Trial Groups. Moore KN, et al. N Engl J Med. 2023 Dec 7;389(23):2162-2174. doi: 10.1056/NEJMoa2309169. N Engl J Med. 2023. PMID: 38055253 Clinical Trial.
Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer.
Leman R, Muller E, Legros A, Goardon N, Chentli I, Atkinson A, Tranchant A, Castera L, Krieger S, Ricou A, Boulouard F, Joly F, Boucly R, Dumont A, Basset N, Coulet F, Chevalier LM, Rouleau E, Leitner K, González-Martin A, Gargiulo P, Lück HJ, Genestie C; PAOLA-1 investigators; Ray-Coquard I, Pujade-Lauraine E, Vaur D. Leman R, et al. Clin Cancer Res. 2023 Nov 1;29(21):4419-4429. doi: 10.1158/1078-0432.CCR-23-0898. Clin Cancer Res. 2023. PMID: 37756555 Free PMC article.
Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial.
Kurtz JE, Pujade-Lauraine E, Oaknin A, Belin L, Leitner K, Cibula D, Denys H, Rosengarten O, Rodrigues M, de Gregorio N, Martinez García J, Petru E, Kocián R, Vergote I, Pautier P, Schmalfeldt B, Gaba L, Polterauer S, Mouret Reynier MA, Sehouli J, Churruca C, Selle F, Joly F, D'Hondt V, Bultot-Boissier É, Lebreton C, Lotz JP, Largillier R, Heudel PE, Heitz F; ATALANTE/ENGOT-ov29 Investigators. Kurtz JE, et al. J Clin Oncol. 2023 Oct 20;41(30):4768-4778. doi: 10.1200/JCO.23.00529. Epub 2023 Aug 29. J Clin Oncol. 2023. PMID: 37643382 Free PMC article. Clinical Trial.
Independent Tissue-Based Biomarkers in Endometrioid Endometrial Cancer: Tumor Budding in Microsatellite Instability and WHO Grading in Copy-Number-Low Patients.
Stögbauer F, Geß B, Brambs C, Lautizi M, Kacprowski T, Ourailidis I, Bronger H, Kiechle M, Noske A, Keller G, Jesinghaus M, Poremba C, Weichert W, Boxberg M. Stögbauer F, et al. Among authors: bronger h. Cancers (Basel). 2023 Jul 28;15(15):3832. doi: 10.3390/cancers15153832. Cancers (Basel). 2023. PMID: 37568650 Free PMC article.
63 results